Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.
Pediatr Surg Int
; 37(2): 287-291, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33394087
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunohistochemistry
/
Extracellular Signal-Regulated MAP Kinases
/
Neuroblastoma
/
Antineoplastic Agents
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
Pediatr Surg Int
Journal subject:
PEDIATRIA
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
Germany